NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Actuate Therapeutics Inc.
Merck Sharp & Dohme LLC
Chinese PLA General Hospital
Verastem, Inc.
Australasian Gastro-Intestinal Trials Group